距离2025年版基本医保目录与首版商保创新药目录正式发布,已过去一个多月。随着1月1日新版目录同步执行,商保支持创新药,终于从制度设计,踏出了走向真实世界的第一步。这一进展,牵动着几乎所有相关方的神经。国家医保局最新披露的数据,提供了一个难得的“早期样本”。截至1月20日,已有99种基本医保目录新增药品在全国12198家定点医药机构销售;与此同时,首版商保创新药目录中,已有14种药品在223家定点...
Source Link距离2025年版基本医保目录与首版商保创新药目录正式发布,已过去一个多月。随着1月1日新版目录同步执行,商保支持创新药,终于从制度设计,踏出了走向真实世界的第一步。这一进展,牵动着几乎所有相关方的神经。国家医保局最新披露的数据,提供了一个难得的“早期样本”。截至1月20日,已有99种基本医保目录新增药品在全国12198家定点医药机构销售;与此同时,首版商保创新药目录中,已有14种药品在223家定点...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.